Overview

Circadian Bio is a young Chronobiology pharmaceutical company, co-founded by the leading research scientists in the Circadian clock domain. The company brings an out-of-the-box novel therapeutic concept, using approved APIs, which enables faster entrainment of both chronic and acute Circadian clock disorders. Circadian Bio's novel innovations are already proptected by a number of patent applications, and the company plans significant expansions in its IP portfoloio within the next couple of years. The company is now in the beginning of a financing round, which will enable it to reach significant value-building milestones within 12 - 18 months.